{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T10:17:10Z","timestamp":1771841830266,"version":"3.50.1"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T00:00:00Z","timestamp":1339977600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0039178","type":"journal-article","created":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T21:08:08Z","timestamp":1340053688000},"page":"e39178","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Paraoxonase-1 Is Not a Major Determinant of Stent Thrombosis in a Taiwanese Population"],"prefix":"10.1371","volume":"7","author":[{"given":"Dong-Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Yung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Shien","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsong-Hai","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Jer","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-Hung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Hung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Chi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laing-Suei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Ta","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"San-Jou","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fun-Chiung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Chang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,6,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCULATIONAHA.107.188208","article-title":"2007 Focused Update of the ACC\/AHA\/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC\/AHA\/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee.","volume":"117","year":"2008","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.","volume":"345","author":"S Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e600","DOI":"10.1161\/CIRCULATIONAHA.106.643171","article-title":"Clopidogrel response variability and future therapies: clopidogrel: does one size fit all?","volume":"114","author":"M O\u2019Donoghue","year":"2006","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jacc.2004.09.067","article-title":"Variability in platelet responsiveness to clopidogrel among 544 individuals.","volume":"45","author":"VL Serebruany","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity.","volume":"107","author":"PA Gurbel","year":"2003","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ahj.2007.04.014","article-title":"Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis.","volume":"154","author":"JD Snoep","year":"2007","journal-title":"Am Heart J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2217\/bmm.10.56","article-title":"Residual platelet reactivity: predicting short- and long-term clinical outcome in patients undergoing percutaneous coronary revascularization.","volume":"4","author":"F Mangiacapra","year":"2010","journal-title":"Biomark Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1160\/TH09-06-0418","article-title":"Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis.","volume":"103","author":"F Sofi","year":"2010","journal-title":"Thromb Haemost"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/dmd.109.029132","article-title":"Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite.","volume":"38","author":"M Kazui","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1182\/blood-2006-04-013052","article-title":"Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects.","volume":"108","author":"JS Hulot","year":"2006","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1111\/j.1538-7836.2007.02775.x","article-title":"Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel.","volume":"5","author":"JT Brandt","year":"2007","journal-title":"J Thromb Haemost"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1111\/j.1538-7836.2007.02722.x","article-title":"Influence of CYP2C19 and CYP3A4 gene polymorphisms on clopidogrel responsiveness in healthy subjects.","volume":"5","author":"P Fontana","year":"2007","journal-title":"J Thromb Haemost"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1538-7836.2008.03050.x","article-title":"The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects.","volume":"6","author":"K Umemura","year":"2008","journal-title":"J Thromb Haemost"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.amjcard.2007.11.065","article-title":"Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndrome.","volume":"101","author":"C Frere","year":"2008","journal-title":"Am J Cardiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.2009.1232","article-title":"Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.","volume":"302","author":"AR Shuldiner","year":"2009","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.amjcard.2008.11.048","article-title":"Relation of Cytochrome P450 2C19 Loss-of-Function Polymorphism to Occurrence of Drug-Eluting Coronary Stent Thrombosis.","volume":"103","author":"B Giusti","year":"2009","journal-title":"The American Journal of Cardiology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/eurheartj\/ehp041","article-title":"Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention.","volume":"30","author":"D Sibbing","year":"2009","journal-title":"Eur Heart J"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel.","volume":"360","author":"JL Mega","year":"2009","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/hrt.2011.227652","article-title":"Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated with clopidogrel.","volume":"98","author":"M Zabalza","year":"2012","journal-title":"Heart"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1161\/01.ATV.0000223867.25324.1a","article-title":"Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel.","volume":"26","author":"DJ Angiolillo","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events.","volume":"360","author":"T Simon","year":"2009","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0167-5273(00)00242-4","article-title":"The human paraoxonase Gln-Argl92 (Q\/R) polymorphism in turkish patients with coronary artery disease.","volume":"74","author":"AS Aynacioglu","year":"2000","journal-title":"Int J Cardiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijcard.2003.05.011","article-title":"PON1 M\/L55 mutation protects high-risk patients against coronary artery disease.","volume":"94","author":"SA Oliveira","year":"2004","journal-title":"Int J Cardiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nm.2281","article-title":"Paraoxonase-1 is a major determinant of clopidogrel efficacy.","volume":"17","author":"HJ Bouman","year":"2010","journal-title":"Nature Medicine"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.111.960112","article-title":"Paraoxonase-1 Q192R Polymorphism and Antiplatelet Effects of Clopidogrel in Patients Undergoing Elective Coronary Stent Placement.","author":"D Trenk","year":"2011"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/eurheartj\/ehr155","article-title":"No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting.","volume":"32","author":"D Sibbing","year":"2011","journal-title":"European Heart Journal"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/clpt.2011.193","article-title":"Effect of Paraoxonase-1 Polymorphism on Clinical Outcomes in Patients Treated With Clopidogrel After an Acute Myocardial Infarction.","volume":"90","author":"T Simon","year":"2011","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"ref28","first-page":"422","article-title":"CYP2C19 But Not PON1 Genetic Variants Influence Clopidogrel Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy in Post-Myocardial Infarction Patients.","volume":"4","author":"JS Hulot","year":"2011","journal-title":"Circulation: Cardiovascular Interventions"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1289\/ehp.9163","article-title":"Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypes.","volume":"114","author":"WF Li","year":"2006","journal-title":"Environ Health Perspect"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/01.ATV.0000051702.38086.C1","article-title":"Extensive Association Analysis Between Polymorphisms of PON Gene Cluster With Coronary Heart Disease in Chinese Han Population.","volume":"23","author":"X Wang","year":"2002","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions.","volume":"115","author":"DE Cutlip","year":"2007","journal-title":"Circulation"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000091834","article-title":"Han Chinese cell and genome bank in Taiwan: purpose, design and ethical considerations.","volume":"61","author":"WH Pan","year":"2006","journal-title":"Hum Hered"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1177\/147323001103900548","article-title":"Relationship between cytochrome P450 2C19*2 polymorphism and stent thrombosis following percutaneous coronary intervention in Chinese patients receiving clopidogrel.","volume":"39","author":"Y Luo","year":"2011","journal-title":"J Int Med Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/clpt.2011.194","article-title":"Paraoxonase 1 (PON1) Gene Variants Are Not Associated With Clopidogrel Response.","volume":"90","author":"JP Lewis","year":"2011","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3346\/jkms.2009.24.4.561","article-title":"Paraoxonase Gene Polymorphism in South-western Korean Population.","volume":"24","author":"BS Shin","year":"2009","journal-title":"Journal of Korean Medical Science"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2217\/14622416.10.3.359","article-title":"Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population.","volume":"10","author":"HH Wang","year":"2009","journal-title":"Pharmacogenomics"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.forsciint.2010.10.004","article-title":"Analysis of 50 SNPs in CYP2D6, CYP2C19, CYP2C9, CYP3A4 and CYP1A2 by MALDI-TOF mass spectrometry in Chinese Han population.","volume":"207","author":"Y Shi","year":"2011","journal-title":"Forensic Science International"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0039178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:18:41Z","timestamp":1540336721000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0039178"}},"subtitle":[],"editor":[{"given":"Michael","family":"Lipinski","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,6,18]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0039178","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,18]]}}}